Top Healthcare stocks:
Healthcare shares were generally flat in pre-market trade on
In healthcare stocks news, Merck & Company (
) said the European Medicines Agency has accepted for review its
marketing authorization application for Pembrolizumab to treat
Merck said it plans regulator filings for the drug in other
countries outside Europe by the end of 2014. The drug is currently
also under review in the U.S.
MRK closed down 1.7% on Friday.
And, Kindred Healthcare (
) said in a letter to Gentiva Health Services' (
) CEO and chairman it wants to sit down to discuss its offer for
the company and also raised concerns about market reports that
Gentiva may be pursuing an acquisition of Amedisys (
Kindred's $14.50 per share all-cash offer was a 70% premium to
Gentiva's closing price on May 14, the day before it made its offer
Finally, Actavis Plc (
) said it is the target of a patent lawsuit that seeks to prevent
the drugmaker from making a generic version of a treatment for
Actavis had filed an abbreviated new drug application with the
U.S. Food and Drug Administration to get approval to sell a generic
version of Zubsolv, which is marketed by Orexo Ab, according to a
statement by Actavis.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.